Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomes.

Anderson, James B; Martin, Stephen A; Gadomski, Anne; Krupa, Nicole; Mullin, Daniel; Cahill, Amber; Jenkins, Paul

Anderson, James B; Martin, Stephen A; Gadomski, Anne; Krupa, Nicole; Mullin, Daniel; Cahill, Amber; Jenkins, Paul.

Afiliación

Anderson JB; Department of Medicine, Bassett Medical Center, Cooperstown, NY, USA.
Martin SA; Family Medicine and Community Health, University of Massachusetts Medical School, Worcester, MA, USA.
Gadomski A; UMassMemorial Healthcare, Worcester, MA, USA.
Krupa N; Bassett Medical Center, Bassett Research Institute, Cooperstown, NY, USA.
Mullin D; Bassett Medical Center, Bassett Research Institute, Cooperstown, NY, USA.
Cahill A; Family Medicine and Community Health, University of Massachusetts Medical School, Worcester, MA, USA.
Jenkins P; UMassMemorial Healthcare, Worcester, MA, USA.

Subst Abus ; 43(1): 222-230, 2022.

Article en En | MEDLINE | ID: mdl-34086529

Asunto(s)

Buprenorfina; Trastornos Relacionados con Opioides; Buprenorfina/uso terapéutico; Humanos; Tratamiento de Sustitución de Opiáceos; Trastornos Relacionados con Opioides/tratamiento farmacológico; Atención Primaria de Salud; Población Rural

Palabras clave

Opioid use disorder; Project ECHO; buprenorphine; medication assisted treatment; medications for opioid use disorder; primary care; treatment retention rate

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Buprenorfina / Trastornos Relacionados con Opioides Límite: Humans Idioma: En Revista: Subst Abus Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google